Status Epilepticus Clinical Trial
— SESIMOfficial title:
Improving Emergency Management of Status Epilepticus - a High-fidelity Simulator-based Randomized Controlled Trial
In the trial the effectiveness of pre-briefing physicians with the current guideline on Status epilepticus (SE) treatment or a consolidated "one page" guideline regarding quality enhancement of the physician's clinical performances is investigated.
Status | Recruiting |
Enrollment | 90 |
Est. completion date | December 2024 |
Est. primary completion date | December 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - Physicians from different medical specialties working at the University Hospital Basel Exclusion Criteria: - None |
Country | Name | City | State |
---|---|---|---|
Switzerland | Clinic for Intensive Care Medicine, University Hospital Basel | Basel |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Basel, Switzerland |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Time to SE recognition (minutes) | time to recognition of seizure and/or SE | from start of simulation training until recognition of seizure and/or SE (max. 20 minutes) | |
Secondary | administration of anti-seizure medication | time of administration of anti-seizure medication (minutes) | within the first 20 minutes after beginning of the simulation training | |
Secondary | dose of anti-seizure medication | dose of anti-seizure medication (mg) | within the first 20 minutes after beginning of the simulation training | |
Secondary | time to correct airways protection | time to correct airways protection (minutes) | from start of simulation training until correct airways protection (max. 20 minutes) | |
Secondary | quantification of Glasgow Coma Score (GCS) | GCS is a neurological scale recording the state of a person's consciousness ; The scale is composed of three tests: eye, verbal and motor responses. The three values separately as well as their sum are considered. The lowest possible GCS (graded 1 in each element) is 3 (deep coma or death), while the highest is 15 (fully awake person). | within the first 20 minutes after beginning of the simulation training |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03378687 -
A Clinical Study of Children With Status Epilepticus in China
|
N/A | |
Recruiting |
NCT00362141 -
Safety and Tolerability Study of Levetiracetam to Treat Patients With Status Epilepticus
|
Phase 2 | |
Recruiting |
NCT05140265 -
De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information
|
||
Active, not recruiting |
NCT04391569 -
Randomized Therapy In Status Epilepticus
|
Phase 3 | |
Recruiting |
NCT06017973 -
The Role of Imaging in the Diagnosis, Management and Prognosis of Possible Non-convulsive Status Epilepticus
|
N/A | |
Completed |
NCT06334796 -
Artificial Intelligence-powered Virtual Assistant for Emergency Triage in Neurology
|
Early Phase 1 | |
Recruiting |
NCT05491590 -
Patient-reported Outcome After Status Epilepticus
|
||
Recruiting |
NCT04421846 -
Study of Pathophysiology of Status Epilepticus and Dysimmune Encephalitis
|
N/A | |
Completed |
NCT02958605 -
Smartphone Apps for Pediatric Resuscitation
|
N/A | |
Completed |
NCT02239380 -
Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan
|
Phase 3 | |
Completed |
NCT01796574 -
Ketogenic Diet for Refractory Status Epilepticus
|
N/A | |
Completed |
NCT02381977 -
Prevalence of Acute Critical Neurological Disease in Children: a Global Epidemiological Assessment
|
N/A | |
Completed |
NCT00004297 -
Phase III Randomized Study of Diazepam Vs Lorazepam Vs Placebo for Prehospital Treatment of Status Epilepticus
|
Phase 3 | |
Completed |
NCT03905798 -
LORA-PITA IV General Investigation
|
||
Recruiting |
NCT05591508 -
Ketogenic Diet for Status Epilepticus in Children Post Cessation of Convulsive Status Epilepticus
|
N/A | |
Completed |
NCT00735527 -
Nasal Versus Venous Lorazepam for Control of Acute Seizures in Children
|
Phase 3 | |
Terminated |
NCT00265616 -
Treatment of Refractory Status Epilepticus
|
Phase 3 | |
Recruiting |
NCT06401707 -
PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest
|
Phase 2 | |
Enrolling by invitation |
NCT06403150 -
The Efficacy and Safety of Levetiracetam Versus Fosphenytoin in Convulsive Status Epilepticus
|
Phase 4 | |
Recruiting |
NCT05246566 -
Assessment of Adults Epidemiological Characteristics of Status Epilepticus in the French West Indies and in French Guiana
|